Delft Instruments (the Netherlands) profits stride ahead:
This article was originally published in Clinica
Executive Summary
Delft Instruments (the Netherlands) has reported net profits of Fl 6.9 million ($4.3 million) in 1994, compared with just Fl 0.1 million in 1993. Turnover rose 17% to Fl 453 million, heavily boosted by the acquisition during the year of Dutch cancer therapy company Nucletron (see Clinica No 624, p 12). Delft says 87% of turnover was outside the Netherlands, with fastest growth in the Far East. The medical sector accounted for 58% of sales. The company expects turnover to reach Fl 500 million in 1995 with a widening of profit margins.